Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF6 | hg38_v1_chr10_-_3785197_3785216 | 0.36 | 4.0e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_219418369 Show fit | 5.72 |
ENST00000373960.4
|
desmin |
|
chr7_+_116525028 Show fit | 4.36 |
ENST00000341049.7
|
caveolin 1 |
|
chr7_+_116524984 Show fit | 4.33 |
ENST00000614113.5
ENST00000393470.1 |
caveolin 1 |
|
chr16_-_66925526 Show fit | 3.32 |
ENST00000299759.11
ENST00000420652.5 |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
|
chr17_+_7023042 Show fit | 2.83 |
ENST00000293805.10
|
BCL6B transcription repressor |
|
chr11_-_65872728 Show fit | 2.65 |
ENST00000528176.5
ENST00000307998.11 |
EGF containing fibulin extracellular matrix protein 2 |
|
chr1_-_21937300 Show fit | 2.55 |
ENST00000374695.8
|
heparan sulfate proteoglycan 2 |
|
chr2_+_42048012 Show fit | 2.49 |
ENST00000294964.6
|
protein kinase domain containing, cytoplasmic |
|
chr11_-_119317119 Show fit | 2.40 |
ENST00000264036.6
|
melanoma cell adhesion molecule |
|
chr17_+_4951080 Show fit | 2.26 |
ENST00000521811.5
ENST00000323997.10 ENST00000522249.5 ENST00000519584.5 ENST00000519602.6 |
enolase 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 8.7 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.2 | 5.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 3.9 | GO:0042092 | type 2 immune response(GO:0042092) |
0.6 | 3.7 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 3.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 3.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 3.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 3.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 3.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 3.0 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 9.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 7.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 5.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 5.7 | GO:0005604 | basement membrane(GO:0005604) |
1.0 | 5.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 4.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 3.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 3.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 2.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 2.4 | GO:0031143 | pseudopodium(GO:0031143) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 8.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 6.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 4.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 4.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.3 | 3.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 3.7 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 3.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 3.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 3.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.6 | 3.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 7.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 6.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 5.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 5.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 3.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 3.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 3.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 7.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 5.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 3.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 2.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 2.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 2.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 2.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |